Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Rare tumor study aims to uncover best treatments for patients

NCT ID NCT07429851

First seen Feb 28, 2026 · Last updated May 23, 2026 · Updated 13 times

Summary

This study looks back at medical records of 34 people with rare, fast-growing neuroendocrine tumors in the lung, thymus, or pancreas. The goal is to compare how these tumors are diagnosed and treated, and to see if patients with different tumor locations have different outcomes. By understanding these differences, doctors hope to improve future treatment decisions for this uncommon cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE CARCINOMA OF LUNG are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • European Institute of Oncology

    RECRUITING

    Milan, Italy, 20141, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.